Suppr超能文献

基于人群的研究:肺巨细胞癌的临床病理特征和预后列线图。

Clinicopathological features and prognostic nomogram of giant cell carcinoma of the lung: A population-based study.

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.

Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, China.

出版信息

Clin Respir J. 2023 Mar;17(3):197-210. doi: 10.1111/crj.13586. Epub 2023 Jan 31.

Abstract

BACKGROUND

Due to its rarity, the features and prognosis of giant cell carcinoma of the lung (GCCL) are not well defined. The present study aimed to describe the clinicopathological features and prognostic analysis of this rare disease, compare it with lung adenocarcinoma (LAC), further determine the prognostic factors and establish a nomogram.

METHODS

Patients diagnosed with GCCL and LAC were identified from the SEER database between 2004 and 2016. The features and survival between GCCL and LAC were compared in the unmatched and matched cohorts after propensity score matching (PSM) analysis. Univariate and multivariate Cox analyses were used to identify the prognostic factors, and a nomogram was constructed. Area under the curve (AUC), C-index, calibration curve and decision curve analysis (DCA) were used to confirm the established nomogram.

RESULTS

A total of 295 patient diagnosed with GCCL and 149 082 patients with LAC were identified. Compared with LAC, patients with GCCL tend to be younger, male, black and have pathological Grade III/IV GCCL, more proportion of AJCC-TNM-IV, T3/T4 and distant metastases. The 1-, 2- and 5-year OS rates of the patients with GCCL were 21.7%, 13.4% and 7.9%, respectively. The median OS and CSS were 3 and 4 months, respectively. Patients with GCCL had significantly shorter OS and CSS than those with LAC in the unmatched and matched cohorts after PSM. Multivariate Cox analysis demonstrated that T, N and M stages and use of chemotherapy and surgery were independent of survival. Furthermore, we constructed a prognostic nomogram for OS and CSS by using independent prognostic factors. The C-index of OS-specific nomogram is 0.78 (0.74-0.81), and the C-index of CSS-specific nomogram is 0.77 (0.73-0.80). The calibration curve and ROC analysis showed good predictive capability of these nomograms. DCA showed that the nomogram had greater clinical practical value in predicting the OS and CSS of GCCL than TNM staging.

CONCLUSION

GCCL have distinct clinicopathological characteristics and significantly worse clinical outcomes. Prognostic nomograms for overall survival (OS) and CSS were constructed.

摘要

背景

由于其罕见性,肺巨细胞癌(GCCL)的特征和预后尚不清楚。本研究旨在描述这种罕见疾病的临床病理特征和预后分析,将其与肺腺癌(LAC)进行比较,进一步确定预后因素并建立列线图。

方法

从 SEER 数据库中检索 2004 年至 2016 年间诊断为 GCCL 和 LAC 的患者。在倾向评分匹配(PSM)分析后,比较未匹配和匹配队列中 GCCL 和 LAC 之间的特征和生存情况。使用单因素和多因素 Cox 分析确定预后因素,并构建列线图。使用曲线下面积(AUC)、C 指数、校准曲线和决策曲线分析(DCA)来验证建立的列线图。

结果

共确定了 295 名诊断为 GCCL 的患者和 149082 名 LAC 患者。与 LAC 相比,GCCL 患者倾向于更年轻、男性、黑人,且病理分级为 III/IV 级 GCCL,AJCC-TNM-IV 分期、T3/T4 期和远处转移的比例更高。GCCL 患者的 1、2 和 5 年 OS 率分别为 21.7%、13.4%和 7.9%。中位 OS 和 CSS 分别为 3 个月和 4 个月。PSM 后,未匹配和匹配队列中,GCCL 患者的 OS 和 CSS 均显著短于 LAC 患者。多因素 Cox 分析表明,T、N 和 M 分期以及化疗和手术的使用是独立的生存因素。此外,我们使用独立的预后因素构建了 OS 和 CSS 的预后列线图。OS 特异性列线图的 C 指数为 0.78(0.74-0.81),CSS 特异性列线图的 C 指数为 0.77(0.73-0.80)。校准曲线和 ROC 分析表明这些列线图具有良好的预测能力。DCA 表明,与 TNM 分期相比,该列线图在预测 GCCL 的 OS 和 CSS 方面具有更大的临床实用价值。

结论

GCCL 具有明显的临床病理特征,临床结局明显较差。建立了用于总体生存(OS)和 CSS 的预后列线图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de81/9978898/066bb0344151/CRJ-17-197-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验